Archean Chemical Industries Ltd (NSE: ACI, BSE: 543657) is a Chennai, Tamil Nadu-based company in the Marine and Bromine Chemicals industry. With a market capitalisation of ₹5,256 Cr, it ranks #819 by market cap among the 6,197 Indian listed companies on FinBizNet. At ₹455.40 (as of 16 Nov 2026), the share price is 28.8% below its 52-week high of ₹639.80 and 10.1% above its 52-week low of ₹413.80. The share price is down 29.9% over one year and down 10.6% over three months.
| Current Price | ₹455.40 |
|---|---|
| Market Cap | ₹5,256 Cr |
| NSE Symbol | ACI |
| BSE Code | 543657 |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Marine and Bromine Chemicals |
| P/E Ratio | 49.5 |
| Return on Equity | 5.55% |
| Return on Assets | 3.62% |
| 52-Week Range | ₹413.80 – ₹639.80 |
| 1-Year Price Change | -29.9% |
| 3-Month Price Change | -10.6% |
| Beta (1Y) | 0.29 |
| Dividend Yield | 0.58% |
| Headquarters | Chennai, Tamil Nadu |
| Website | www.archeanchemicals.com |
| Revenue | ₹297 Cr |
|---|---|
| Net Profit | ₹31 Cr |
| Net Margin | 10.5% |
| EPS (Basic) | ₹2.60 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Archean Chemical Industries Ltd reported revenue of ₹297 Cr in Q2 FY27, up 27.5% from ₹233 Cr in Q2 FY26 and down 9.1% from ₹327 Cr in Q1 FY27. It posted a net profit of ₹31 Cr for the quarter, against a net profit of ₹29 Cr in Q2 FY26 (up 7.9%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹233 Cr (Q2 FY26) to ₹346 Cr (Q4 FY25). The company was profitable in each of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹297 Cr | ₹31 Cr | 10.5% |
| Q1 FY27 | ₹327 Cr | ₹30 Cr | 9.3% |
| Q4 FY26 | ₹301 Cr | ₹12 Cr | 4.1% |
| Q3 FY26 | ₹255 Cr | ₹24 Cr | 9.4% |
| Q2 FY26 | ₹233 Cr | ₹29 Cr | 12.5% |
| Q1 FY26 | ₹292 Cr | ₹40 Cr | 13.7% |
| Q4 FY25 | ₹346 Cr | ₹54 Cr | 15.6% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 53.43% of Archean Chemical Industries Ltd's shares as of Sept 2026, against 53.44% in Sept 2025 (−0.01 percentage points). Delivery averaged 49.7% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for agrochemicals, medical, glass, cosmetics, and medical users industries. The company was founded in 2003 and is based in Chennai, India.
1. Marine Chemicals-This segment produces and supplies marine chemicals. It offers industrial salt, liquid bromine, and sulphate of potash chemicals. 2. NA-NA 3. NA-NA 4. NA-NA
1. Marine Chemicals-100%
Archean Chemical Industries Ltd is trading at ₹455.40, with a market capitalisation of ₹5,256 Cr.
Archean Chemical Industries Ltd operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Marine and Bromine Chemicals).
Archean Chemical Industries Ltd has a P/E of 49.5 and a return on equity of 5.55%.
Archean Chemical Industries Ltd is listed on the NSE under the symbol ACI and on the BSE under the scrip code 543657.
Archean Chemical Industries Ltd's share price is down 29.9% over one year and down 10.6% over three months. Its 52-week range is ₹413.80 to ₹639.80.
In Q2 FY27, Archean Chemical Industries Ltd reported revenue of ₹297 Cr and net profit of ₹31 Cr, with basic EPS of ₹2.6 (consolidated, parsed from the company's exchange filing).
Archean Chemical Industries Ltd reported revenue of ₹297 Cr in Q2 FY27, up 27.5% from ₹233 Cr in Q2 FY26 and down 9.1% from ₹327 Cr in Q1 FY27.
Promoters held 53.43% of Archean Chemical Industries Ltd's shares as of Sept 2026, against 53.44% in Sept 2025 (−0.01 percentage points).
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.